ACR

5.45%

5.8¢ acrux limited

Ann: Acrux presents at BioTrinity-ACR.AX, page-15

First 15 Last

Share
Profile

Follow
Slogger

7,566 Posts.

706

17/05/16

07:58

Post #: 17784583
Share

Originally posted by mwilson25 ↑

Thanks for these contributions. I am hoping to get a slightly higher price for my remaining shares so I guess positive recommendations are good.

I have no way to verify where we stand with the FDA, but certainly the court cases are in my view no reason to curtail marketing efforts. Given we have a strong case that all is well, then market away. Ditto with the FDA unless some behind the scenes gentleman's agreement has been struck in which Lilly agrees to keep marketing low key to avoid a warning on the bottle. I suppose the latter is possible. Anyway you bring an interesting perspective on this, that was not in my mind.

The Wilson stuff is likely just management PR. I have one company in my portfolio which told their analyst a whole lot of rot that led to a buy recommendation (not spec buy but buy) and a glowing analyst report, only to find just 8 weeks later that they are on the verge of going into administration and are in talks with suppliers to stitch up a deal to keep them afloat!!!!! Sp down 60% since the buy reco. The analysts know that if they keep in good with management then they get chosen for doing CRs and other work where they charge fat fees. Got to be careful unless we see some real measurable facts about progress. The absence of such facts and evidence of proper planning and scheduling is one of my main beefs with ACR management. I am not buying Wilson's view myself

Expand

totally agree - Wilson stuff is just PR - the Bio presentation should have had "similar" output by management but a lot of good that did to the SP. and target now only $0.70 - wasn't it $1 not too long ago by another firm??. I don't take any notice of these target prices by brokers - all self interest IMO. and as for FDA - yes Mitta very interesting take.

ACR Price at posting: 66.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

IMA

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 34 more messages in this thread...

First 15 Last

Add ACR (ASX) to my watchlist

(20min delay)
Last 5.8¢		Change 0.003(5.45%)		Mkt cap ! $16.86M

Open	High	Low	Value	Volume
5.4¢	5.8¢	5.4¢	$7.047K	123.4K

Buyers (Bids)

No.	Vol.	Price($)
1	22861	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.8¢	17257	1

View Market Depth

No.	Vol.	Price($)
1	22861	0.056
1	37735	0.053
1	168669	0.052
3	119539	0.051
2	217490	0.050

Price($)	Vol.	No.
0.058	17257	1
0.060	670	1
0.061	100000	1
0.062	116100	2
0.063	111500	2

Last trade - 16.10pm 11/10/2024 (20 minute delay)

ACR (ASX) Chart

Ann: Acrux presents at BioTrinity-ACR.AX, page-15

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Cauldron Energy reports "excellent" uranium assays in latest drill run

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

NRW Holdings inks $109M deal with BHP for works at Jimblebar

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Acrux presents at BioTrinity-ACR.AX, page-15

Top Stories

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Cauldron Energy reports "excellent" uranium assays in latest drill run

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

NRW Holdings inks $109M deal with BHP for works at Jimblebar

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News